ÂÜÀòÂÒÂ×

Eva Colás is the CSO and co-founder of MiMARK, a biotech company based in Barcelona, Spain. Eva was previously a postdoc researcher at the Institut de Recerca Biomédica de Lleida and the Vall d’Hebron Institute of Research (VHIR). Eva completed their PhD at the Hospital Universitari de la Vall d'Hebron in 2011. Her research has focused on the development of new therapeutic strategies for treating cancer.

Eva Colás began their educational career by obtaining a Bachelor of Biology from Universitat de Barcelona. Eva then continued their education by obtaining a Bachelor of Biology from University of Bergen (UiB).

They are on a team with Antonio Gil - CMO & Co-Founder, Anna Fàbregas - Regulatory & Quality Specialist, and Jordi Petit - Financial Lead. Eva Colás reports to Marina Rigau, CEO & Co-Founder.